Bispecific Antibodies Market Report

China Bispecific Antibodies Industry Market Research Report 2023-2029

  • POSTDATE：Sep 07, 2023
  • PAGES：230
  • REPORT CODE：GMM1781877
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Bispecific Antibodies industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Merus

    • EMD Serono

    • Eli Lilly

    • Jounce Therapeutics

    • Ablynx

    • Chugai Pharmaceutical

    • Adimab

    • Emergent BioSolutions

    • NovImmune SA

    • Neovii Biotech

    • Affimed Therapeutics

    • Genmab

    • Genentech

    By Type:

    • Dual-Variable-Domain Immunoglobulin Approach

    • Quadroma (Hybrid Hydromas) Approach

    • CrossMab Approach

    • “Knobs Into Holes” Approach

    By Application:

    • BsAbs Blocking Signaling Pathways

    • BsAbs Targeting Tumor Angiogenesis

    • BsMAb for Diagnosis of Bacterial & Viral Infectious Diseases

    • Bispecific Antibodies & Gene Therapy

    • Specific Delivery of Effector Compounds to Targets

    • BsMAb for Cancer Diagnostic

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Bispecific Antibodies Market Overview 2018-2029

    • 1.1 China Bispecific Antibodies Industry Development Overview

    • 1.2 China Bispecific Antibodies Industry Development History

    • 1.3 China Bispecific Antibodies Industry Market Size (2018-2029)

    • 1.4 China Bispecific Antibodies Market Analysis by Type from Production Side

      • 1.4.1 China Bispecific Antibodies Production Volume, Production Value and Growth Rate of Dual-Variable-Domain Immunoglobulin Approach (2018-2029)

      • 1.4.2 China Bispecific Antibodies Production Volume, Production Value and Growth Rate of Quadroma (Hybrid Hydromas) Approach (2018-2029)

      • 1.4.3 China Bispecific Antibodies Production Volume, Production Value and Growth Rate of CrossMab Approach (2018-2029)

      • 1.4.4 China Bispecific Antibodies Production Volume, Production Value and Growth Rate of “Knobs Into Holes” Approach (2018-2029)

    • 1.5 China Bispecific Antibodies Market Analysis by Application from Consumption End

      • 1.5.1 China Bispecific Antibodies Sales Volume, Sales Value and Growth Rate of BsAbs Blocking Signaling Pathways (2018-2029)

      • 1.5.2 China Bispecific Antibodies Sales Volume, Sales Value and Growth Rate of BsAbs Targeting Tumor Angiogenesis (2018-2029)

      • 1.5.3 China Bispecific Antibodies Sales Volume, Sales Value and Growth Rate of BsMAb for Diagnosis of Bacterial & Viral Infectious Diseases (2018-2029)

      • 1.5.4 China Bispecific Antibodies Sales Volume, Sales Value and Growth Rate of Bispecific Antibodies & Gene Therapy (2018-2029)

      • 1.5.5 China Bispecific Antibodies Sales Volume, Sales Value and Growth Rate of Specific Delivery of Effector Compounds to Targets (2018-2029)

      • 1.5.6 China Bispecific Antibodies Sales Volume, Sales Value and Growth Rate of BsMAb for Cancer Diagnostic (2018-2029)

    • 1.6 China Bispecific Antibodies Market Analysis by Region

      • 1.6.1 North China Bispecific Antibodies Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Bispecific Antibodies Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Bispecific Antibodies Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Bispecific Antibodies Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Bispecific Antibodies Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Bispecific Antibodies Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Bispecific Antibodies Market Size and Growth Rate from 2018-2029

    Chapter 2 China Bispecific Antibodies Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Bispecific Antibodies Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Bispecific Antibodies Market Status and Competition Analysis in 2023

      • 2.2.3 China Bispecific Antibodies Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Bispecific Antibodies Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Bispecific Antibodies Industry Development

    Chapter 3 Bispecific AntibodiesIndustry Chain Analysis

    • 3.1 Bispecific Antibodies Industry Chain

    • 3.2 Bispecific Antibodies Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Bispecific Antibodies Market

    • 3.3 Bispecific Antibodies Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Bispecific Antibodies Market

    Chapter 4 China Bispecific Antibodies Market, by Type

    • 4.1 China Bispecific Antibodies Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Bispecific Antibodies Total Production Volume and Growth Rate from Production Side

    • 4.5 China Bispecific Antibodies Production Volume and Growth Rate, by Type

      • 4.5.1 China Bispecific Antibodies Production Volume and Growth Rate of Dual-Variable-Domain Immunoglobulin Approach

      • 4.5.2 China Bispecific Antibodies Production Volume and Growth Rate of Quadroma (Hybrid Hydromas) Approach

      • 4.5.3 China Bispecific Antibodies Production Volume and Growth Rate of CrossMab Approach

      • 4.5.4 China Bispecific Antibodies Production Volume and Growth Rate of “Knobs Into Holes” Approach

    Chapter 5 China Bispecific Antibodies Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Bispecific Antibodies Total Market Size and Growth Rate from Consumption End

    • 5.5 China Bispecific Antibodies Market Size and Growth Rate, by Application

      • 5.5.1 China Bispecific Antibodies Market Size and Growth Rate of BsAbs Blocking Signaling Pathways

      • 5.5.2 China Bispecific Antibodies Market Size and Growth Rate of BsAbs Targeting Tumor Angiogenesis

      • 5.5.3 China Bispecific Antibodies Market Size and Growth Rate of BsMAb for Diagnosis of Bacterial & Viral Infectious Diseases

      • 5.5.4 China Bispecific Antibodies Market Size and Growth Rate of Bispecific Antibodies & Gene Therapy

      • 5.5.5 China Bispecific Antibodies Market Size and Growth Rate of Specific Delivery of Effector Compounds to Targets

      • 5.5.6 China Bispecific Antibodies Market Size and Growth Rate of BsMAb for Cancer Diagnostic

    Chapter 6 China Bispecific Antibodies Market, by Region

    • 6.1 China Bispecific Antibodies Production Volume and Production Value, by Region

    • 6.2 China Bispecific Antibodies Sales Volume and Sales Value, by Region

    Chapter 7 North China Bispecific Antibodies Market Analysis

    • 7.1 North China Bispecific Antibodies Market, by Type

    • 7.2 North China Bispecific Antibodies Market, by Application

    Chapter 8 Central China Bispecific Antibodies Market Analysis

    • 8.1 Central China Bispecific Antibodies Market, by Type

    • 8.2 Central China Bispecific Antibodies Market, by Application

    Chapter 9 South China Bispecific Antibodies Market Analysis

    • 9.1 South China Bispecific Antibodies Market, by Type

    • 9.2 South China Bispecific Antibodies Market, by Application

    Chapter 10 East China Bispecific Antibodies Market Analysis

    • 10.1 East China Bispecific Antibodies Market, by Type

    • 10.2 East China Bispecific Antibodies Market, by Application

    Chapter 11 Northeast China Bispecific Antibodies Market Analysis

    • 11.1 Northeast China Bispecific Antibodies Market, by Type

    • 11.2 Northeast China Bispecific Antibodies Market, by Application

    Chapter 12 Southwest China Bispecific Antibodies Market Analysis

    • 12.1 Southwest China Bispecific Antibodies Market, by Type

    • 12.2 Southwest China Bispecific Antibodies Market, by Application

    Chapter 13 Northwest China Bispecific Antibodies Market Analysis

    • 13.1 Northwest China Bispecific Antibodies Market, by Type

    • 13.2 Northwest China Bispecific Antibodies Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Merus

        • 14.1.1 Merus Company Profile

        • 14.1.2 Merus Bispecific Antibodies Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 EMD Serono

        • 14.2.1 EMD Serono Company Profile

        • 14.2.2 EMD Serono Bispecific Antibodies Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Eli Lilly

        • 14.3.1 Eli Lilly Company Profile

        • 14.3.2 Eli Lilly Bispecific Antibodies Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Jounce Therapeutics

        • 14.4.1 Jounce Therapeutics Company Profile

        • 14.4.2 Jounce Therapeutics Bispecific Antibodies Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Ablynx

        • 14.5.1 Ablynx Company Profile

        • 14.5.2 Ablynx Bispecific Antibodies Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Chugai Pharmaceutical

        • 14.6.1 Chugai Pharmaceutical Company Profile

        • 14.6.2 Chugai Pharmaceutical Bispecific Antibodies Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Adimab

        • 14.7.1 Adimab Company Profile

        • 14.7.2 Adimab Bispecific Antibodies Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Emergent BioSolutions

        • 14.8.1 Emergent BioSolutions Company Profile

        • 14.8.2 Emergent BioSolutions Bispecific Antibodies Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 NovImmune SA

        • 14.9.1 NovImmune SA Company Profile

        • 14.9.2 NovImmune SA Bispecific Antibodies Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Neovii Biotech

        • 14.10.1 Neovii Biotech Company Profile

        • 14.10.2 Neovii Biotech Bispecific Antibodies Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Affimed Therapeutics

        • 14.11.1 Affimed Therapeutics Company Profile

        • 14.11.2 Affimed Therapeutics Bispecific Antibodies Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Genmab

        • 14.12.1 Genmab Company Profile

        • 14.12.2 Genmab Bispecific Antibodies Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Genentech

        • 14.13.1 Genentech Company Profile

        • 14.13.2 Genentech Bispecific Antibodies Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Bispecific Antibodies Industry Research Conclusions

    • 15.2 Bispecific Antibodies Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Bispecific Antibodies Industry Market Size (2018-2029)

    • Figure China Bispecific Antibodies Production Volume, Production Value and Growth Rate of Dual-Variable-Domain Immunoglobulin Approach (2018-2029)

    • Figure China Bispecific Antibodies Production Volume, Production Value and Growth Rate of Quadroma (Hybrid Hydromas) Approach (2018-2029)

    • Figure China Bispecific Antibodies Production Volume, Production Value and Growth Rate of CrossMab Approach (2018-2029)

    • Figure China Bispecific Antibodies Production Volume, Production Value and Growth Rate of “Knobs Into Holes” Approach (2018-2029)

    • Figure China Bispecific Antibodies Sales Volume, Sales Value and Growth Rate of BsAbs Blocking Signaling Pathways (2018-2029)

    • Figure China Bispecific Antibodies Sales Volume, Sales Value and Growth Rate of BsAbs Targeting Tumor Angiogenesis (2018-2029)

    • Figure China Bispecific Antibodies Sales Volume, Sales Value and Growth Rate of BsMAb for Diagnosis of Bacterial & Viral Infectious Diseases (2018-2029)

    • Figure China Bispecific Antibodies Sales Volume, Sales Value and Growth Rate of Bispecific Antibodies & Gene Therapy (2018-2029)

    • Figure China Bispecific Antibodies Sales Volume, Sales Value and Growth Rate of Specific Delivery of Effector Compounds to Targets (2018-2029)

    • Figure China Bispecific Antibodies Sales Volume, Sales Value and Growth Rate of BsMAb for Cancer Diagnostic (2018-2029)

    • Figure North China Bispecific Antibodies Market Size and Growth Rate from 2018-2029

    • Figure Central China Bispecific Antibodies Market Size and Growth Rate from 2018-2029

    • Figure South China Bispecific Antibodies Market Size and Growth Rate from 2018-2029

    • Figure East China Bispecific Antibodies Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Bispecific Antibodies Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Bispecific Antibodies Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Bispecific Antibodies Market Size and Growth Rate from 2018-2029

    • Figure Bispecific Antibodies Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Bispecific Antibodies Market Share by Type in 2018

    • Figure China Bispecific Antibodies Market Share by Type in 2023

    • Figure China Bispecific Antibodies Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Bispecific Antibodies Production Volume and Growth Rate of Dual-Variable-Domain Immunoglobulin Approach (2018-2023)

    • Figure China Bispecific Antibodies Production Volume and Growth Rate of Quadroma (Hybrid Hydromas) Approach (2018-2023)

    • Figure China Bispecific Antibodies Production Volume and Growth Rate of CrossMab Approach (2018-2023)

    • Figure China Bispecific Antibodies Production Volume and Growth Rate of “Knobs Into Holes” Approach (2018-2023)

    • Figure China Bispecific Antibodies Market Share by Application in 2018

    • Figure China Bispecific Antibodies Market Share by Application in 2023

    • Figure China Bispecific Antibodies Total Market Size and Growth Rate from Consumption End

    • Figure China Bispecific Antibodies Market Size and Growth Rate of BsAbs Blocking Signaling Pathways (2018-2023)

    • Figure China Bispecific Antibodies Market Size and Growth Rate of BsAbs Targeting Tumor Angiogenesis (2018-2023)

    • Figure China Bispecific Antibodies Market Size and Growth Rate of BsMAb for Diagnosis of Bacterial & Viral Infectious Diseases (2018-2023)

    • Figure China Bispecific Antibodies Market Size and Growth Rate of Bispecific Antibodies & Gene Therapy (2018-2023)

    • Figure China Bispecific Antibodies Market Size and Growth Rate of Specific Delivery of Effector Compounds to Targets (2018-2023)

    • Figure China Bispecific Antibodies Market Size and Growth Rate of BsMAb for Cancer Diagnostic (2018-2023)

    • Table China Bispecific Antibodies Production Volume by Region (2018-2023)

    • Table China Bispecific Antibodies Production Volume Share by Region (2018-2023)

    • Figure China Bispecific Antibodies Production Volume Share by Region (2018-2023)

    • Table China Bispecific Antibodies Production Value by Region (2018-2023)

    • Table China Bispecific Antibodies Production Value Share by Region (2018-2023)

    • Figure China Bispecific Antibodies Production Value Share by Region (2018-2023)

    • Table China Bispecific Antibodies Sales Volume by Region (2018-2023)

    • Table China Bispecific Antibodies Sales Volume Share by Region (2018-2023)

    • Figure China Bispecific Antibodies Sales Volume Share by Region (2018-2023)

    • Table China Bispecific Antibodies Sales Value by Region (2018-2023)

    • Table China Bispecific Antibodies Sales Value Share by Region (2018-2023)

    • Figure China Bispecific Antibodies Sales Value Share by Region (2018-2023)

    • Table North China Bispecific Antibodies Production Volume by Type (2018-2023)

    • Table North China Bispecific Antibodies Production Volume Share by Type (2018-2023)

    • Figure North China Bispecific Antibodies Production Volume Share by Type (2018-2023)

    • Table North China Bispecific Antibodies Sales Volume by Application (2018-2023)

    • Table North China Bispecific Antibodies Sales Volume Share by Application (2018-2023)

    • Figure North China Bispecific Antibodies Sales Volume Share by Application (2018-2023)

    • Table Central China Bispecific Antibodies Production Volume by Type (2018-2023)

    • Table Central China Bispecific Antibodies Production Volume Share by Type (2018-2023)

    • Figure Central China Bispecific Antibodies Production Volume Share by Type (2018-2023)

    • Table Central China Bispecific Antibodies Sales Volume by Application (2018-2023)

    • Table Central China Bispecific Antibodies Sales Volume Share by Application (2018-2023)

    • Figure Central China Bispecific Antibodies Sales Volume Share by Application (2018-2023)

    • Table South China Bispecific Antibodies Production Volume by Type (2018-2023)

    • Table South China Bispecific Antibodies Production Volume Share by Type (2018-2023)

    • Figure South China Bispecific Antibodies Production Volume Share by Type (2018-2023)

    • Table South China Bispecific Antibodies Sales Volume by Application (2018-2023)

    • Table South China Bispecific Antibodies Sales Volume Share by Application (2018-2023)

    • Figure South China Bispecific Antibodies Sales Volume Share by Application (2018-2023)

    • Table East China Bispecific Antibodies Production Volume by Type (2018-2023)

    • Table East China Bispecific Antibodies Production Volume Share by Type (2018-2023)

    • Figure East China Bispecific Antibodies Production Volume Share by Type (2018-2023)

    • Table East China Bispecific Antibodies Sales Volume by Application (2018-2023)

    • Table East China Bispecific Antibodies Sales Volume Share by Application (2018-2023)

    • Figure East China Bispecific Antibodies Sales Volume Share by Application (2018-2023)

    • Table Northeast China Bispecific Antibodies Production Volume by Type (2018-2023)

    • Table Northeast China Bispecific Antibodies Production Volume Share by Type (2018-2023)

    • Figure Northeast China Bispecific Antibodies Production Volume Share by Type (2018-2023)

    • Table Northeast China Bispecific Antibodies Sales Volume by Application (2018-2023)

    • Table Northeast China Bispecific Antibodies Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Bispecific Antibodies Sales Volume Share by Application (2018-2023)

    • Table Southwest China Bispecific Antibodies Production Volume by Type (2018-2023)

    • Table Southwest China Bispecific Antibodies Production Volume Share by Type (2018-2023)

    • Figure Southwest China Bispecific Antibodies Production Volume Share by Type (2018-2023)

    • Table Southwest China Bispecific Antibodies Sales Volume by Application (2018-2023)

    • Table Southwest China Bispecific Antibodies Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Bispecific Antibodies Sales Volume Share by Application (2018-2023)

    • Table Northwest China Bispecific Antibodies Production Volume by Type (2018-2023)

    • Table Northwest China Bispecific Antibodies Production Volume Share by Type (2018-2023)

    • Figure Northwest China Bispecific Antibodies Production Volume Share by Type (2018-2023)

    • Table Northwest China Bispecific Antibodies Sales Volume by Application (2018-2023)

    • Table Northwest China Bispecific Antibodies Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Bispecific Antibodies Sales Volume Share by Application (2018-2023)

    • Table Merus Company Profile

    • Table Merus Bispecific Antibodies Revenue, Price and Gross (2018-2023)

    • Table EMD Serono Company Profile

    • Table EMD Serono Bispecific Antibodies Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Bispecific Antibodies Revenue, Price and Gross (2018-2023)

    • Table Jounce Therapeutics Company Profile

    • Table Jounce Therapeutics Bispecific Antibodies Revenue, Price and Gross (2018-2023)

    • Table Ablynx Company Profile

    • Table Ablynx Bispecific Antibodies Revenue, Price and Gross (2018-2023)

    • Table Chugai Pharmaceutical Company Profile

    • Table Chugai Pharmaceutical Bispecific Antibodies Revenue, Price and Gross (2018-2023)

    • Table Adimab Company Profile

    • Table Adimab Bispecific Antibodies Revenue, Price and Gross (2018-2023)

    • Table Emergent BioSolutions Company Profile

    • Table Emergent BioSolutions Bispecific Antibodies Revenue, Price and Gross (2018-2023)

    • Table NovImmune SA Company Profile

    • Table NovImmune SA Bispecific Antibodies Revenue, Price and Gross (2018-2023)

    • Table Neovii Biotech Company Profile

    • Table Neovii Biotech Bispecific Antibodies Revenue, Price and Gross (2018-2023)

    • Table Affimed Therapeutics Company Profile

    • Table Affimed Therapeutics Bispecific Antibodies Revenue, Price and Gross (2018-2023)

    • Table Genmab Company Profile

    • Table Genmab Bispecific Antibodies Revenue, Price and Gross (2018-2023)

    • Table Genentech Company Profile

    • Table Genentech Bispecific Antibodies Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US